150.86

0.59% 0.88

Dopo l'orario di chiusura: 150.86

Agilent Technologies Inc (A)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché A Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$149.98

Aprire:

$148.97

Volume 24 ore:

1.81M

Relative Volume:

0.82

Capitalizzazione di mercato:

$42.61B

Reddito:

$7.23B

Utile/perdita netta:

$1.41B

Rapporto P/E:

30.30

EPS:

4.979

Flusso di cassa netto:

$1.09B

1 W Prestazione:

-1.94%

1M Prestazione:

+8.38%

6M Prestazione:

+25.15%

1 anno Prestazione:

+17.42%

Intervallo 1D:

$147.78

$151.59

Intervallo di 1 settimana:

$147.60

$154.59

Portata 52W:

$108.35

$163.75

Agilent Technologies Inc Stock (A) Company Profile

Nome

Agilent Technologies Inc

Settore

Healthcare (1074)

Industria

Diagnostics & Research (50)

Telefono

(408) 345-8886

Indirizzo

5301 STEVENS CREEK BLVD, SANTA CLARA, CA

Dipendente

18,100

Cinguettio

@agilent

Prossima data di guadagno

2026-08-26

Ultimi documenti SEC

A's Discussions on Twitter

Compare A vs TMO, DHR, NTRA, IQV

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
A Agilent Technologies Inc	150.86	44.14B	7.23B	1.41B	1.09B	4.979
TMO Thermo Fisher Scientific Inc	613.78	232.03B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	207.66	151.78B	24.78B	3.68B	5.29B	5.1743
NTRA Natera Inc	328.18	46.82B	2.50B	-226.32M	71.51M	-1.6412
IQV Iqvia Holdings Inc	267.77	42.15B	16.63B	1.39B	2.12B	8.0674

Agilent Technologies Inc Stock (A) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-01-20	Iniziato	HSBC Securities	Buy
2026-01-05	Aggiornamento	Evercore ISI	In-line → Outperform
2025-12-15	Aggiornamento	Barclays	Equal Weight → Overweight
2025-12-09	Iniziato	Goldman	Buy
2025-12-02	Iniziato	Morgan Stanley	Overweight
2025-10-08	Iniziato	Rothschild & Co Redburn	Buy
2025-10-08	Aggiornamento	UBS	Neutral → Buy
2025-02-10	Aggiornamento	Barclays	Underweight → Equal Weight
2024-08-28	Iniziato	Wells Fargo	Overweight
2024-07-10	Aggiornamento	Citigroup	Neutral → Buy
2024-06-27	Downgrade	Wolfe Research	Outperform → Peer Perform
2024-06-03	Ripresa	Jefferies	Hold
2024-04-05	Aggiornamento	Stifel	Hold → Buy
2023-12-13	Iniziato	Wolfe Research	Outperform
2023-12-12	Downgrade	BofA Securities	Buy → Neutral
2023-11-17	Downgrade	UBS	Buy → Neutral
2023-09-28	Iniziato	Bernstein	Mkt Perform
2023-07-31	Downgrade	Evercore ISI	Outperform → In-line
2023-05-24	Reiterato	Barclays	Equal Weight
2023-05-24	Reiterato	BofA Securities	Buy
2023-05-24	Reiterato	Citigroup	Neutral
2023-05-24	Reiterato	Credit Suisse	Outperform
2023-05-24	Reiterato	Evercore ISI	Outperform
2023-05-24	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
2023-05-24	Reiterato	Robert W. Baird	Outperform
2023-05-24	Reiterato	SVB Securities	Outperform
2023-05-24	Reiterato	Stifel	Hold
2023-05-24	Reiterato	TD Cowen	Outperform
2023-05-24	Reiterato	Wells Fargo	Overweight
2023-05-11	Iniziato	Barclays	Equal Weight
2023-01-10	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2022-08-25	Iniziato	Credit Suisse	Outperform
2022-07-20	Iniziato	UBS	Buy
2022-07-08	Downgrade	Citigroup	Buy → Neutral
2022-04-25	Downgrade	Wells Fargo	Overweight → Equal Weight
2022-02-23	Reiterato	BofA Securities	Buy
2022-02-23	Reiterato	Citigroup	Buy
2022-02-23	Reiterato	Cowen	Outperform
2022-02-23	Reiterato	Evercore ISI	Outperform
2022-02-23	Reiterato	Stifel	Hold
2022-02-23	Reiterato	Wells Fargo	Overweight
2021-11-23	Reiterato	BofA Securities	Buy
2021-11-23	Reiterato	Cowen	Outperform
2021-11-23	Reiterato	Stifel	Hold
2021-03-18	Aggiornamento	Citigroup	Neutral → Buy
2021-02-17	Aggiornamento	BofA Securities	Neutral → Buy
2020-12-02	Iniziato	Goldman	Buy
2020-11-25	Aggiornamento	UBS	Neutral → Buy
2020-11-17	Aggiornamento	Cleveland Research	Neutral → Buy
2020-11-10	Iniziato	KeyBanc Capital Markets	Overweight
2020-09-30	Iniziato	Atlantic Equities	Neutral
2020-08-19	Reiterato	BofA Securities	Neutral
2020-08-19	Reiterato	Citigroup	Neutral
2020-08-19	Reiterato	Jefferies	Buy
2020-08-19	Reiterato	Robert W. Baird	Outperform
2020-08-19	Reiterato	SVB Leerink	Outperform
2020-08-19	Reiterato	Stifel	Hold
2020-08-19	Reiterato	Wells Fargo	Overweight
2020-02-24	Downgrade	Needham	Buy → Hold
2020-01-08	Iniziato	Wells Fargo	Overweight
2020-01-07	Iniziato	Citigroup	Neutral
2019-11-26	Reiterato	Needham	Buy
2019-11-15	Iniziato	Stifel	Hold
2019-10-18	Downgrade	UBS	Buy → Neutral
2019-07-16	Downgrade	BofA/Merrill	Buy → Neutral
2019-07-15	Downgrade	Barclays	Overweight → Equal Weight

Mostra tutto

Agilent Technologies Inc Borsa (A) Ultime notizie

Sep 06, 2026

Agilent Technologies stock gains as FDA-cleared S540MD slide scanner strengthens digital pathology p - AD HOC NEWS

Sep 06, 2026

Sep 04, 2026

Agilent Technologies | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo

Sep 04, 2026

Mikael Dolsten to sell Agilent (NYSE: A) stock - Stock Titan

Sep 04, 2026

Worker says Agilent fired him to mask race and age bias - hcamag.com

Sep 04, 2026

Agilent Technologies stock gains on digital pathology launch and strong Q3 figures - AD HOC NEWS

Sep 04, 2026

Agilent Expands Digital Pathology Offering with U.S. Launch of the Agilent S540MD Slide Scanner System - 01net

Sep 04, 2026

Agilent Technologies Launches FDA-Cleared S540MD Slide Scanner in US - marketscreener.com

Sep 04, 2026

Agilent launches FDA-cleared slide scanner in U.S. market By Investing.com - Investing.com Australia

Sep 04, 2026

Global Multiplex Assays Market 2026 Edition - GlobeNewswire Inc.

Sep 04, 2026

Sep 03, 2026

Baird Adjusts Price Target on Agilent Technologies to $180 From $169, Keeps Outperform Rating - marketscreener.com

Sep 03, 2026

Sep 02, 2026